Proposal for screening of kidney disease in a random population based on World Kidney Day campaign

Marcelo Bacci, Victor Jordão, Livia Vasconcelos, Thiago Castanheira, Ronaldo Bergamo, Daniel Santos, Ana Carolina Mottecy, Ligia Azzalis, Edimar Pereira, Beatriz Alves, Fernando Fonseca


Despite the advances on early screening techniques, getting to know the chronic kidney disease (CKD) prevalence in Brazil and worldwide remains a challenge for researchers. Aging, diabetes and hypertension are the main CKD causes in Brazil. The aim of the study was to evaluate the presence of urinary dipstick abnormalities in World Kidney Day campaign. This is a cross-sectional studyconducted at FMABC. This study was based on the answers to a kidney disease questionnaire and urinary dipstick test. A total of 205 patients were randomly invited to collect urine samples on World Kidney Day 2013. Among the 205 studied patients, 66.34% were women with mean age of 46.32 years. Around 34.14% of the patients were hypertensive and 9.75% diabetic. Urinalysis alterations were observed in 28.29% of patients. The group with urine alterations had older individuals (51.36 years) andmore diabetes (18.96%) with higher levels of glucose (143.2 mg/dl).  Brazilian population is getting older and diabetic which represent risk factors for the onset of CKD. The necessity of an early detection by means of specific campaigns is thus of great importance. The use of dipstick test for screening is an important tool for kidney disease diagnosis.


Proteinuria; Diabetes; Hypertension

Full Text:



Lugon JR. Chronic kidney disease in Brazil: a health care problem. J Bras Nefrol. 2009; 3(Supl 1): 2-5.

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic disease: global dimension and perspectives. Lancet. 2013; 382: 260-272.

Brazilian Dialysis Report 2014. [Accessed 08/20/2015].

Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi K, Moriyama T, et al. Cost-effectiveness of chronic kidney disease in Japan with dipstick test. Clin Exp Nephrol. 2012; 16: 279-291.

American Diabetes Association: Standards of medical care in diabetes - 2013. Diabetes Care. 2013; 36(Suppl 1): S11-66.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Presure. The JNC 7 report. JAMA. 2003; 289: 2560-2572.

Bastos MG, Kirsztajn GM. Chronic kidney disease: importance of early diagnosis, immediate referral and structured interdisciplinary approach to improve outcomes in patients not yet on dialysis. J Bras Nefrol. 2011; 33: 93-108.

de Lima AO, Kesrouani S, Gomes RA, Cruz J, Mastroianni-Kirsztajn G. Population screening for chronic kidney disease: a survey involving 38,721 Brazilians. Nephrol Dial Transplant. 2012; 27(Suppl 3): iii135-138.

Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012; 156: 570-581.

Moyer VA. U.S. Preventive Services Task Force: Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157: 567-570.

Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, et al. and on behalf of the European CKD Burden Consortium. CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2015; 27(7): 2135-2147.

European Kidney Health Alliance. Improving kidney care in Europe. The Alarming Rise in Chronic Kidney Disease in Europe: How to deal with this costly problem.


  • There are currently no refbacks.